Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
The Gas6/Axl pathway has been increasingly implicated in regeneration and tissue repair and, recently, in the control of innate immunity. In liver, we have demonstrated that Gas6 and its receptor Axl are expressed in macrophages, progenitor cells, and myofibroblasts and that Gas6 deficiency reduced inflammation and myofibroblast activation, causing delayed liver repair in response to acute injury. All these data suggest a role of Gas6/Axl signaling in pathogenesis of chronic liver diseases. In the present study, we address the role of Gas6 in steatohepatitis and progression to liver fibrosis using Gas6-deficient mice fed a choline-deficient ethionine-supplemented diet (CDE) or receiving a chronic carbon tetrachloride (CCl 4) treatment. Gas6 deficiency attenuated hepatic steatosis by limiting CDE-induced downregulation of genes involved in β-oxidation observed in wild-type animals. Moreover, Gas6-deficient mice displayed reduction of hepatic inflammation, revealed by limited F4/80-positive macrophage infiltration, decreased expression of IL-1β, TNF-α, lymphotoxin-β, and monocyte chemotactic protein-1, and attenuated hepatic progenitor cell response to CDE diet. Gas6 deficiency reduced CDE-induced fibrogenesis and hepatic myofibroblast activation and decreased expression of TGF-β and collagen 1 mRNAs. After chronic CCl 4 injury, Gas6-deficient mice also exhibited reduced liver fibrosis as a consequence of defective macrophage recruitment compared with wild-type animals. We conclude that improvement of steatohepatitis and fibrosis in Gas6−/−mice is linked to an inhibition of the inflammatory response that controls lipid metabolism and myofibroblast activation. This study highlights the deleterious effect of Gas6 in the progression of steatosis to steatohepatitis and fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215 · cited 1×
“Other recent studies revealed that TAM receptors have a pivotal role in the control of innate immunity (24) and that Gas6/TAM signaling is involved in inflammation by enhancing interactions between endothelial cells and leukocytes (41) as well as by facilitating the engulfment of apoptotic bodies by macrophages (38).”
BackgroundTAM Receptors Are Pleiotropic Inhibitors of the Innate Immune Response
Rothlin, C. V., Ghosh, S., Zuniga, E. I., Oldstone, M. B. A., & Lemke, G. (2007) · Cell · doi:10.1016/j.cell.2007.10.034 · Cited by 1,055 · cited 3×
“Since Axl tempers the inflammatory response (35), overexpression of this receptor in Gas6 / mice could prevent progression to steatohepatitis with CDE diet and fibrosis after chronic CCl4 injury.”
BackgroundRivera, C. A., Adegboyega, P., van Rooijen, N., Tagalicud, A., Allman, M., & Wallace, M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.019 · Cited by 693 · cited 9×
“Kupffer cells are the primary source of IL-1 and their depletion reduces liver steatosis during MCD (33) and chronic high-fat feeding (40).”
BackgroundInfluentialYao, Z. M., & Vance, D. E. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69166-5 · Cited by 618 · cited 1×
“Choline deficiency induces hepatocyte fat storage through an inhibition of phosphatidylcholine synthesis necessary to liver VLDL assembly and secretion (45).”
BackgroundHuang, W., Metlakunta, A., Dedousis, N., Zhang, P., Sipula, I., Dube, J. J., Scott, D. K., & O'Doherty, R. M. (2010) · Diabetes · doi:10.2337/db09-0016 · Cited by 520
Richardson, M. M., Jonsson, J. R., Powell, E. E., Brunt, E. M., Neuschwander–Tetri, B. A., Bhathal, P. S., Dixon, J. B., Weltman, M. D., Tilg, H., Moschen, A. R., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.012 · Cited by 482 · cited 4×
“The persistent lowgrade inflammation due to chronic hepatocyte damage plays also a critical role in LPC expansion, which may play a part in fibrosis (4, 23, 31, 34).”
BackgroundMethodInfluentialStienstra, R., Saudale, F., Duval, C., Keshtkar, S., Groener, J. E. M., van Rooijen, N., Staels, B., Kersten, S., & Müller, M. (2010) · Hepatology · doi:10.1002/hep.23337 · Cited by 452 · cited 3×
“acid oxidation (40), it can be hypothesized that reduced IL-1 expression revealed in Gas6 / mice prevents early CDEinduced downregulation of genes involved in -oxidation in hepatocytes and steatosis.”
BackgroundClouston, A. D., Powell, E. E., Walsh, M. J., Richardson, M. M., Demetris, A. J., & Jonsson, J. R. (2005) · Hepatology · doi:10.1002/hep.20650 · Cited by 361
Hepatic Steatosis: A Mediator of the Metabolic Syndrome. Lessons From Animal Models
den Boer, M., Voshol, P. J., Kuipers, F., Havekes, L. M., & Romijn, J. A. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000116217.57583.6e · Cited by 260
Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells
Hasanbasic, I., Cuerquis, J., Varnum, B., & Blostein, M. D. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00020.2004 · Cited by 156 · cited 1×
“The Gas6/Axl pathway promotes hematopoietic stem cell growth (8) and fibroblast or endothelial cell survival (12, 39) and has been implicated in regeneration and tissue repair (27).”
Background
Cited by
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Graham, D. K., DeRyckere, D., Davies, K. D., & Earp, H. S. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3847 · Cited by 698
TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis
van der Meer, J. H. M., van der Poll, T., & van ‘t Veer, C. (2014) · Blood · doi:10.1182/blood-2013-09-528752 · Cited by 343
Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis
Cai, B., Dongiovanni, P., Corey, K. E., Wang, X., Shmarakov, I. O., Zheng, Z., Kasikara, C., Davra, V., Meroni, M., Chung, R. T., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.013 · Cited by 266
“In this context, holo-knockout of Gas6 in a model of steatohepatitis has been shown to lessen liver inflammation and fibrosis, although in this study there was no link to TAM receptors per se (Fourcot et al., 2011).”
BackgroundLuo, X.-Y., Takahara, T., Kawai, K., Fujino, M., Sugiyama, T., Tsuneyama, K., Tsukada, K., Nakae, S., Zhong, L., & Li, X.-K. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00193.2013 · Cited by 120
Shearn, C. T., Reigan, P., & Petersen, D. R. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.04.021 · Cited by 42
Metadata
- Authors
- Fourcot, A., Couchie, D., Chobert, M.-N., Zafrani, E.-S., Mavier, P., Laperche, Y., & Brouillet, A.
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2011-06
- Volume
- 300
- Issue
- 6
- Pages
- G1043-G1053
- ISSN
- 0193-1857 (ISSN-L)
- 1522-1547
- OpenAlex
- W2120648280
- Cited by
- 69
- References
- 11
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice. https://app.cochat.ai/papers/10.1152/ajpgi.00311.2010
- The paper
- Fourcot, A., Couchie, D., Chobert, M.-N., Zafrani, E.-S., Mavier, P., Laperche, Y., & Brouillet, A. (2011). Gas6 deficiency prevents liver inflammation, steatohepatitis, and fibrosis in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00311.2010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.